Nicole C Ammerman (Nicole Ammerman)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 16

Top Topics

Multidrug Resistant

Pulmonary Tuberculosis

Radical Prostatectomy

Electronic Health Record

Top Venues

Antimicrobial agents and chemotherapy

bioRxiv : the preprint server for biology

American journal of respiratory and critical care medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Jurriaan E M De Steenwinkel, Nicole C Ammerman, Marian T Ten Kate, Nader Fotouhi, Manisha U Lotlikar, Hannelore I Bax, Jurriaan E M de Steenwinkel
Relative contributions of the novel diarylquinoline TBAJ-876 and its active metabolite to the bactericidal activity in a murine model of tuberculosis. The Journal of infectious diseases (2024)
Yong S Chang, Si-Yang Li, Henry Pertinez, Fabrice Betoudji, Jin Lee, Steven P Rannard, Andrew Owen, Eric L Nuermberger, Nicole C Ammerman
Using dynamic oral dosing of rifapentine and rifabutin to simulate exposure profiles of long-acting formulations in a mouse model of tuberculosis preventive therapy. bioRxiv : the preprint server for biology (2023)
Yong S Chang, Si-Yang Li, Henry Pertinez, Fabrice Betoudji, Jin Lee, Steven P Rannard, Andrew Owen, Eric L Nuermberger, Nicole C Ammerman
Using Dynamic Oral Dosing of Rifapentine and Rifabutin to Simulate Exposure Profiles of Long-Acting Formulations in a Mouse Model of Tuberculosis Preventive Therapy. Antimicrobial agents and chemotherapy (2023)
Yong S Chang, Si-Yang Li, Henry Pertinez, Fabrice Betoudji, Jin Lee, Steven P Rannard, Andrew Owen, Eric L Nuermberger, Nicole C Ammerman
Using dynamic oral dosing of rifapentine and rifabutin to simulate exposure profiles of long-acting formulations in a mouse model of tuberculosis preventive therapy. bioRxiv : the preprint server for biology (2023)
Yong S Chang, Si-Yang Li, Henry Pertinez, Fabrice Betoudji, Jin Lee, Steven P Rannard, Andrew Owen, Eric L Nuermberger, Nicole C Ammerman
Using dynamic oral dosing of rifapentine and rifabutin to simulate exposure profiles of long-acting formulations in a mouse model of tuberculosis preventive therapy. bioRxiv : the preprint server for biology (2023)
Amit Kaushik, Nicole C Ammerman, Rokeya Tasneen, Sophie Lachau-Durand, Koen Andries, Eric L Nuermberger
Efficacy of Long-Acting Bedaquiline Regimens in a Mouse Model of Tuberculosis Preventive Therapy. American journal of respiratory and critical care medicine 205 (5) (2022)
Alexander Berg, James Clary, Debra Hanna, Eric L Nuermberger, Anne Lenaerts, Nicole C Ammerman, Michelle Ramey, Dan Hartley, David Hermann
Model-Based Meta-Analysis of Relapsing Mouse Model Studies from the Critical Path to Tuberculosis Drug Regimens Initiative Database. Antimicrobial agents and chemotherapy 66 (3) (2022)
Olumide Martins, Jin Lee, Amit Kaushik, Nicole C Ammerman, Kelly E Dooley, Eric L Nuermberger
In Vitro Activity of Bedaquiline and Imipenem against Actively Growing, Nutrient-Starved, and Intracellular Mycobacterium abscessus. Antimicrobial agents and chemotherapy 65 (12) (2021)
Jin Lee, Nicole C Ammerman, Anusha Agarwal, Maram Naji, Si-Yang Li, Eric L Nuermberger
Differential In Vitro Activities of Individual Drugs and Bedaquiline-Rifabutin Combinations against Actively Multiplying and Nutrient-Starved Mycobacterium abscessus. Antimicrobial agents and chemotherapy 65 (2) (2021)
Steven Dunne, Andrew R Willmer, Rosemary Swanson, Deepak Almeida, Nicole C Ammerman, Kathleen A Stringer, Edmund V Capparelli, Gus R Rosania
Quantitative Analysis of the Phase Transition Mechanism Underpinning the Systemic Self-Assembly of a Mechanopharmaceutical Device. Pharmaceutics 14 (1) (2021)
Andrew R Willmer, Steven Dunne, Rosemary Swanson, Deepak Almeida, Nicole C Ammerman, Kathleen A Stringer, Edmund V Capparelli, Gus R Rosania
An Adaptive Biosystems Engineering Approach towards Modeling the Soluble-to-Insoluble Phase Transition of Clofazimine. Pharmaceutics 14 (1) (2021)
Kendra K Radtke, Jacqueline P Ernest, Nan Zhang, Nicole C Ammerman, Eric L Nuermberger, Robert Belknap, Rosanna Boyd, Timothy R Sterling, Radojka M Savic
Comparative Efficacy of Rifapentine Alone and in Combination with Isoniazid for Latent Tuberculosis Infection: a Translational Pharmacokinetic-Pharmacodynamic Modeling Study. Antimicrobial agents and chemotherapy 65 (12) (2021)
Amit Kaushik, Nicole C Ammerman, Sandeep Tyagi, Vikram Saini, Iwan Vervoort, Sophie Lachau-Durand, Eric Nuermberger, Koen Andries
Activity of a Long-Acting Injectable Bedaquiline Formulation in a Paucibacillary Mouse Model of Latent Tuberculosis Infection. Antimicrobial agents and chemotherapy 63 (4) (2019)
Amit Kaushik, Nicole C Ammerman, Jin Lee, Olumide Martins, Barry N Kreiswirth, Gyanu Lamichhane, Nicole M Parrish, Eric L Nuermberger
In Vitro Activity of the New β-Lactamase Inhibitors Relebactam and Vaborbactam in Combination with β-Lactams against Mycobacterium abscessus Complex Clinical Isolates. Antimicrobial agents and chemotherapy 63 (3) (2019)
Vikram Saini, Nicole C Ammerman, Yong Seok Chang, Rokeya Tasneen, Richard E Chaisson, Sanjay Jain, Eric Nuermberger, Jacques H Grosset
Treatment-Shortening Effect of a Novel Regimen Combining Clofazimine and High-Dose Rifapentine in Pathologically Distinct Mouse Models of Tuberculosis. Antimicrobial agents and chemotherapy 63 (6) (2019)
Nicole C Ammerman, Rosemary V Swanson, Elaine M Bautista, Deepak V Almeida, Vikram Saini, Till F Omansen, Haidan Guo, Yong Seok Chang, Si-Yang Li, Asa Tapley, Rokeya Tasneen, Sandeep Tyagi, Fabrice Betoudji, Chivonne Moodley, Bongani Ngcobo, Logan Pillay, Linda A Bester, Sanil D Singh, Richard E Chaisson, Eric L Nuermberger, Jacques H Grosset
Impact of Clofazimine Dosing on Treatment Shortening of the First-Line Regimen in a Mouse Model of Tuberculosis. Antimicrobial agents and chemotherapy 62 (7) (2018)